IPO registrations (S-1, F-1) · Registrants
DGI RESOLUTION INC
- SEC CIK
- 1022974 · filings on EDGAR ↗
- Name on the registration
- DECODE GENETICS INC
- Former names
- DECODE GENETICS INC (2000–2010)
- Registration
- Form S-1, first filed 2000-03-08, last 2000-07-13; 1 initial registration, 5 amendments
- Outcome
- Final prospectus filed 2000-07-18
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 8 STURLUGATA, IS 101, Reyjkavik, K6 00000
- EIN
- 04-3326704
- EDGAR entity type
- operating
- Insiders and CEO pay
- DGI RESOLUTION INC on the corporate pages
Offering terms
- Proposed price range
- $14.00–$18.00 per share (S-1/A filed 2000-07-13)
- Final price
- $18.00 per share, within the range (424B4 filed 2000-07-18, an initial public offering)
- Shares sold
- 9,600,000
- Gross proceeds
- $172,800,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol DCGN
- Lead underwriters
- Morgan Stanley (6,240,000 shares)
- Syndicate
- Lehman Brothers (3,360,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: DECODE GENETICS INC EXACT (CIK (EXACT))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-03-08 | S-1 | S-1 (registration) | DECODE GENETICS INC | 0000950123-00-002076 ↗ |
| 2000-05-05 | S-1/A | S-1/A (amendment) | DECODE GENETICS INC | 0000893220-00-000610 ↗ |
| 2000-06-01 | S-1/A | S-1/A (amendment) | DECODE GENETICS INC | 0000893220-00-000732 ↗ |
| 2000-06-19 | S-1/A | S-1/A (amendment) | DECODE GENETICS INC | 0000893220-00-000772 ↗ |
| 2000-07-06 | S-1/A | S-1/A (amendment) | DECODE GENETICS INC | 0000893220-00-000840 ↗ |
| 2000-07-13 | S-1/A | S-1/A (amendment) | DECODE GENETICS INC | 0000893220-00-000862 ↗ |
| 2000-07-17 | S-1MEF | S-1MEF (added securities) | DECODE GENETICS INC | 0000950123-00-006595 ↗ |
| 2000-07-18 | 424B4 | 424B4 (final prospectus) | DECODE GENETICS INC | 0000950123-00-006624 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-07-13 | S-1/A | registration statement | $14.00–$18.00 | $16.00 | 9,200,000 | $147,200,000 | Nasdaq DCGN | 4 | primary document; range, price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
| 2000-07-18 | 424B4 | final prospectus | $18.00 | 9,600,000 | $172,800,000 | Nasdaq DCGN | 2 | primary document; price sentence, shares headline, proceeds computed, underwriting table 2, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Hartman Daniel L | Officer | Sr. V.P., Product Development; Sr. VP Product Development | 4 | 2006–2008 | |
| ARMSTRONG J NEAL | Director | 4 | 2006–2009 | ||
| BEERY JAMES | Director | 4 | 2006–2009 | ||
| MCGUIRE TERRANCE | Director | 4 | 2006–2008 | ||
| Sigurdsson Tomas | Officer | V.P., Treasury & New Alliances | 1 | 2006 | |
| Stattin Norinder Birgit A | Director | 3 | 2006–2008 | ||
| COLLIER EARL M JR | Director | 4 | 2006–2009 | ||
| Goodfellow Peter | Director | 3 | 2006–2007 | ||
| Sigurdsson Jakob O | Officer | Sr. V.P. Corporate Development; Sr. V.P.,Corporate Development; Sr. VP, Corporate Development; S.V.P., Corporate Development | 5 | 2006–2008 | |
| GURNEY MARK | Officer | Sr.V.P.Drug Discovery&Develop; Sr. VP Drug Discovery & Dvlpmt; Sr. VP Drug Discovery & Dvpmt | 3 | 2007–2008 | |
| STEFANSSON KARI | Officer | Chairman, President & CEO; Chariman, President & CEO | 2 | 2007–2008 | |
| THIBAULT LANCE E | Officer | CFO & Treasurer | 2 | 2007–2008 | |
| Zharov Tanya | Officer | V.P. Corp. Governance & Admin; VP, Corporate Governance & Adm | 2 | 2007 | |
| NIELSEN AXEL | Officer | Chief Operating Officer | 3 | 2007–2008 | |
| Buck Linda B | Director | 1 | 2008 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | DECODE GENETICS INC | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, K6 first:
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
- PRA INTERNATIONAL INC VA
- QUEST DIAGNOSTICS INVESTMENTS INC NJ
- SIGNAL PHARMACEUTICALS INC CA
- CURAGEN CORP MA
- DELTAGEN INC CA
- BIORELIANCE CORP MD
- KENDLE INTERNATIONAL INC OH
- VARIAGENICS INC MA
In other datasets, the same topic (Medical research) in K6:
- Form D issuer: Kerecis hf (Form D private offerings)
Interests: Services-Commercial Physical & Biological Research · Medical research